As part of the participation at the 13th International Conference on Nuclear Sciences and Applications, Rosatom showcased technologies in medicine, healthcare, and agriculture.
ROSATOM, a global technological leader, participated in the 13th International Conference on Nuclear Sciences and Applications organized by the Egyptian Society of Nuclear Sciences and Applications (ESNSA) and Egyptian Atomic Energy Authority (EAEA) from February 17 to 20 in Hurghada, Egypt. The conference, held every four years, serves as a vital platform for exploring the latest activities and advancements in nuclear sciences and their wide-ranging applications.
The opening ceremony was attended by Chairman of Egyptian Atomic Energy Authority Prof. Dr. Amr Elhag-Ali, Chairman of ESNSA Prof. Dr. Hisham Fouad Aly, Scientific Secretary of ESNSA Prof. Dr. Abdel Fattah Helal, honorable members of the conference’s steering committee and representatives of the local and regional business community.
Murad Aslanov, Director of the Rosatom Country Office in Egypt, attended the opening ceremony, where he showcased the company’s portfolio of products and solutions in spheres like medicine and agriculture. From her side, Dr. Irina Svyato, adviser to the General Director of the “Health Technologies” Rosatom Division, delivered a presentation about the nuclear medicine development in Russia. According to the speaker, Rosatom offers the market 16 types of popular medical equipment of its own design and production, as well as an integrated approach to implementing medical infrastructure facilities. Rosatom, one of the world leaders in the production of medical isotopes, produces 11 radiopharmaceuticals for the diagnosis, treatment, and theranostics of oncological and cardiovascular diseases. It is also implementing one of the most important projects in the field of healthcare today – the construction of Europe’s largest radiopharmaceutical production plant in the city of Obninsk (Russia). Speaker also talked about the Rosatom’s multipurpose centers for processing products with ionizing radiation, which not only serve to sterilize medical devices. Using ionizing radiation technologies based on such centers, being safe for human health, helps the processing of agricultural products. As a result, the shelf life of food products increases several times. “Such centers can make a serious contribution to the improving of food security and increase export potential,” the speaker noted.
“ROSATOM’s advancements in nuclear sciences and its applications stand as a testament to our commitment to technological innovation. The opening of our flagship office in Egypt marks a significant milestone in collaboration with Egyptian partners, namely within the field of medicine. Last year we signed an agreement with Egyptian company “Med Pharma Group” aimed at integration of nitric-oxide into medical practice in the Arab Republic of Egypt based on the “Tianox” device, one of the most advanced and unique nitric oxide therapy units for adults and children. We are confident that this collaboration will contribute to Egypt’s medical sector further development”, said Murad Aslanov, Director of Rosatom Country Office in Egypt.
